Global Bioenergies Balance Sheet Health
Financial Health criteria checks 3/6
Global Bioenergies has a total shareholder equity of €2.8M and total debt of €12.5M, which brings its debt-to-equity ratio to 448.2%. Its total assets and total liabilities are €18.3M and €15.5M respectively.
Key information
448.2%
Debt to equity ratio
€12.45m
Debt
Interest coverage ratio | n/a |
Cash | €11.84m |
Equity | €2.78m |
Total liabilities | €15.48m |
Total assets | €18.25m |
Recent financial health updates
Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?
Jun 28Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?
Oct 11Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?
Oct 25Recent updates
Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?
Jun 28Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?
Oct 11Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?
Oct 25Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain
Mar 20Financial Position Analysis
Short Term Liabilities: ALGBE's short term assets (€15.0M) exceed its short term liabilities (€3.0M).
Long Term Liabilities: ALGBE's short term assets (€15.0M) exceed its long term liabilities (€12.5M).
Debt to Equity History and Analysis
Debt Level: ALGBE's net debt to equity ratio (21.9%) is considered satisfactory.
Reducing Debt: ALGBE's debt to equity ratio has increased from 145.4% to 448.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ALGBE has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALGBE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.